Health ❯Healthcare

Side Effects

Pharmaceuticals Side Effects Patient Care Clinical Trials Government Initiatives Contraception Clinical Research Market Performance Vaccines Vaccine Regulation

FDA Approves Moderna’s mNEXSPIKE for High-Risk Populations

Rollout is planned for the 2025-26 respiratory virus season under a new policy limiting COVID-19 boosters to high-risk groups.

FDA Warns of Rare Severe Itching After Stopping Common Allergy Medications

New Data Confirms Low Risk of Severe Side Effects for Alzheimer’s Drug Lecanemab

UK to Provide Free Morning-After Pill at Pharmacies to End Access Inequities